Tag: AstraZeneca
AstraZeneca's US listing creates £200 mn UK stamp‑duty gap
AstraZeneca's triple‑listing plan exempts US‑traded Depositary Interests from UK stamp duty, carving a £200 mn revenue hole for the Treasury while keeping the drugmaker in the FTSE 100.